TELA Bio, Inc.
NASDAQ:TELA
2.99 (USD) • At close November 7, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | TELA Bio, Inc. |
Symbool | TELA |
Munteenheid | USD |
Prijs | 2.99 |
Beurswaarde | 109,774,262 |
Dividendpercentage | 0% |
52-weken bereik | 2.3 - 7.84 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Antony Koblish |
Website | https://www.telabio.com |
An error occurred while fetching data.
Over TELA Bio, Inc.
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)